Amoxicillin/Potassium Clav
Brand name: Amoxicillin-Clavulanate Potass
Rank #380 of 500 drugs by total cost
$25.3M
Total Cost
2,207,997
Total Claims
$25.3M
Total Cost
82,871
Prescribers
$11
Cost per Claim
1,856,319
Beneficiaries
2,216,599
30-Day Fills
$305
Avg Cost/Provider
27
Avg Claims/Provider
About Amoxicillin/Potassium Clav
Amoxicillin/Potassium Clav (sold as Amoxicillin-Clavulanate Potass) was prescribed 2,207,997 times by 82,871 Medicare Part D providers in 2023, costing the program $25.3M. At $11 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 377 | Tezepelumab-Ekko (Tezspire) | $25.6M | 5,900 |
| 378 | Ponatinib Hcl (Iclusig) | $25.6M | 1,209 |
| 379 | Citalopram Hydrobromide (Citalopram Hbr) | $25.3M | 2,778,255 |
| 380 | Amoxicillin/Potassium Clav (Amoxicillin-Clavulanate Potass) | $25.3M | 2,207,997 |
| 381 | Infliximab (Remicade) | $25.3M | 3,457 |
| 382 | Glimepiride (Glimepiride) | $25.3M | 1,885,737 |
| 383 | Flecainide Acetate (Flecainide Acetate) | $25.1M | 412,334 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology